INS and metabolic dysfunction-associated steatohepatitis: Rather, Peptide 2 supplementation improves IR and rescues insulin-regulated lipolysis in WAT while tending to reduce LD area, decreasing inflammation, and possibly preventing fibrosis, crucial processes to prevent NAFLD progression to NASH.